文献速递眼底病与葡萄膜炎

内皮细胞特异性分子1阻断抑制小鼠实验性眼新生血管

Endocan Blockade Suppresses Experimental Ocular Neovascularization in Mice.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究在小鼠氧诱导视网膜病变、脉络膜新生血管及视紫红质启动子/VEGF转基因三种模型中评估内皮细胞特异性分子1(endocan)的表达,发现其显著升高;玻璃体内注射中和抗体阻断endocan可抑制视网膜、脉络膜及视网膜下新生血管面积并降低多种血管生成相关分子,重组endocan蛋白可直接诱导人视网膜微血管内皮细胞(HREC)管腔形成。

要点

  • endocan在三种小鼠眼新生血管模型中表达显著升高。
  • 玻璃体内注射endocan中和抗体可抑制视网膜、脉络膜及视网膜下新生血管面积。
  • 重组endocan蛋白可直接诱导HREC管腔形成。

核心结论

  • 当前数据提示endocan是视网膜及视网膜下新生血管疾病的潜在治疗靶点或附加靶点。

研究设计与样本

  • 研究采用氧诱导视网膜病变(OIR)、脉络膜新生血管(CNV)及视紫红质启动子(rho)/VEGF转基因小鼠三种模型。
  • 采用定量实时PCR(RT-PCR)和Western blot评估endocan表达。
  • 体内实验用特异性功能抗体中和endocan,通过RT-PCR、Western blot及铺片免疫染色评估眼新生血管水平。
  • 体外实验用常规方法观察endocan对人视网膜微血管内皮细胞(HREC)管腔形成的影响。

主要发现

  • endocan在三种实验小鼠模型中均显著升高。
  • 玻璃体内注射中和剂阻断endocan不仅抑制视网膜、脉络膜及视网膜下新生血管面积,还导致多种血管生成相关分子减少。
  • 重组endocan蛋白(rhEndocan)可直接诱导HREC管腔形成。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Ocular neovascularization (NV) is a pathologic process characterized by the proliferation and infiltration of various types of cells such as RPE, glial, and endothelial cells, which interact with proangiogenic factors and inflammatory cytokines. Endocan is known to be enriched in retinal endothelial tip cells under hypoxia, but the effect of endocan on ocular NV progression is largely unknown. In this study, we investigated the role of endocan in the ocular NV pathologic process and the possible mechanisms involved. METHODS: In the eyes of mice with oxygen-induced retinopathy (OIR); choroidal NV (CNV); and rhodopsin promoter (rho)/VEGF transgenic mice, endocan expression was assessed by quantitative real-time PCR (RT-PCR) and Western blot. In vivo, a specific functional antibody was used to neutralize endocan and ocular NV levels were evaluated by RT-PCR, Western blot and immunostaining of flat-mounts. In vitro, the effect of endocan on human retinal microvascular endothelial cell (HREC) tube formation was observed using a routine method. RESULTS: Endocan was significantly elevated in these three experimental mice models. Endocan blockade with the neutralizer intravitreal injection not only suppressed the area of retinal, choroidal and subretinal NV, but also resulted in a decrease in several angiogenesis-associated molecules. Recombinant endocan protein (rhEndocan) was found to induce tube formation on HRECs directly. CONCLUSIONS: The current data suggest that endocan is a potential therapeutic or an additional target for retinal and subretinal NV diseases.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Su T, Zhong Y, Demetriades AM, et al. Endocan Blockade Suppresses Experimental Ocular Neovascularization in Mice. Invest Ophthalmol Vis Sci. 2018. PMID: 29450540. doi:10.1167/iovs.17-22945

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。